| MeSH term | MeSH ID | Detail |
|---|---|---|
| Foot Rot | D005535 | 1 associated lipids |
| Frostbite | D005627 | 1 associated lipids |
| Strongyle Infections, Equine | D013319 | 1 associated lipids |
| Basal Ganglia Hemorrhage | D020145 | 1 associated lipids |
| Edema, Cardiac | D004489 | 1 associated lipids |
| Osteoblastoma | D018215 | 1 associated lipids |
| Radiculopathy | D011843 | 1 associated lipids |
| Oligomenorrhea | D009839 | 1 associated lipids |
| Erythromelalgia | D004916 | 1 associated lipids |
| Intracranial Hemorrhage, Hypertensive | D020299 | 1 associated lipids |
| Cholecystitis, Acute | D041881 | 1 associated lipids |
| Bluetongue | D001819 | 1 associated lipids |
| Atrial Premature Complexes | D018880 | 1 associated lipids |
| Gastric Dilatation | D013271 | 1 associated lipids |
| Latex Hypersensitivity | D020315 | 1 associated lipids |
| Stomach Volvulus | D013277 | 1 associated lipids |
| Pulmonary Heart Disease | D011660 | 2 associated lipids |
| Drowning | D004332 | 2 associated lipids |
| Aortic Arch Syndromes | D001015 | 2 associated lipids |
| Mixed Connective Tissue Disease | D008947 | 2 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Herrick AL et al. | Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. | 1996 | Ann. Rheum. Dis. | pmid:8712862 |
| Tishler M et al. | Salivary eicosanoid concentration in patients with Sjögren's syndrome. | 1996 | Ann. Rheum. Dis. | pmid:8712887 |
| Mitten LA et al. | Phenylbutazone increases right atrial pressure and heart rate of running horses. | 1996 | J. Appl. Physiol. | pmid:8828679 |
| Myers SI et al. | Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8888351 |
| Collins CE et al. | Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. | 1996 | Aliment. Pharmacol. Ther. | pmid:8791957 |
| Eriksson M et al. | Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. | 1996 | Acta Anaesthesiol Scand | pmid:8792882 |
| Izaki S et al. | Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. | 1996 | Br. J. Dermatol. | pmid:8763425 |
| Shirabe K et al. | Inhibition of thromboxane A2 activity during warm ischemia of the liver. | 1996 | J. Surg. Res. | pmid:8769950 |
| Myers SI et al. | Long-term resuscitation of hemorrhage/reperfusion injury (H/R) stimulates renal PGE2 release. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8832762 |
| Abernathy VJ et al. | C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. | 1996 | Am. J. Physiol. | pmid:8770090 |
| Closa D et al. | Hepatic involvement in pancreatitis-induced lung damage. | 1996 | Am. J. Physiol. | pmid:8772495 |
| Fleisch JH et al. | Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8764358 |
| Jacoby RF et al. | Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. | 1996 | Cancer Res. | pmid:8631000 |
| Wahle KW and Peacock LI | Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. | 1996 | Biochim. Biophys. Acta | pmid:8652649 |
| Belisario MA et al. | In vitro effect of avarone and avarol, a quinone/hydroquinone couple of marine origin, on platelet aggregation. | 1996 | Pharmacol. Toxicol. | pmid:9000256 |
| Haimovich B et al. | The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets. | 1996 | J. Biol. Chem. | pmid:8663117 |
| Jancinová V et al. | Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. | 1996 | Blood Coagul. Fibrinolysis | pmid:8735816 |
| Ravn HB et al. | Magnesium inhibits human platelets. | 1996 | Blood Coagul. Fibrinolysis | pmid:8735829 |
| Young JM et al. | Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. | 1996 | Inflamm. Res. | pmid:8737748 |
| Laffi G et al. | Defective aggregation in cirrhosis is independent of in vivo platelet activation. | 1996 | J. Hepatol. | pmid:8738730 |
| Ko FN et al. | Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. | 1996 | J. Pharm. Pharmacol. | pmid:8794990 |
| Yoshida T et al. | Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. | 1996 | Lupus | pmid:8743126 |
| Oláh L et al. | [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. | 1996 | Orv Hetil | pmid:8714038 |
| Kruse-Elliott KT et al. | Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. | 1996 | Shock | pmid:8721386 |
| Yanase T et al. | Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. | 1996 | Shock | pmid:8721389 |
| Yan DH et al. | [Study on experimental parameters for diagnosing ganyang huafeng syndrome of cerebral infarction]. | 1996 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:9772617 |
| Pfister SL and Campbell WB | Role of endothelium-derived metabolites of arachidonic acid in enhanced pulmonary artery contractions in female rabbits. | 1996 | Hypertension | pmid:8591886 |
| Isozaki H et al. | Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. | 1996 | Surg. Today | pmid:8727944 |
| Dayal S et al. | Increased ratio of thromboxane B2 and 6-keto PGF1 alpha in patients of hepatic venous outflow obstruction. | 1996 | Eur. J. Haematol. | pmid:8982298 |
| Liang XC et al. | [Study on relationship of lipid peroxide in coronary heart disease with and without diabetes]. | 1996 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:8732128 |
| Santini G et al. | Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases. | 1996 | Eur. J. Pharmacol. | pmid:8982652 |
| Nagao T et al. | Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats. | 1996 | Eur. J. Pharmacol. | pmid:8982653 |
| Tarnow P et al. | Effects of D-myo-Inositol-1,2,6-triphosphate on eicosanoid formation in burned skin. | 1996 | J. Surg. Res. | pmid:8606494 |
| Praticó D and FitzGerald GA | Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. | 1996 | J. Biol. Chem. | pmid:8621535 |
| Okada M et al. | Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent. | 1996 | Immunology | pmid:8911154 |
| Cuiper LL et al. | Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. | 1996 | J. Appl. Physiol. | pmid:8847301 |
| Qiu BS et al. | Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. | 1996 | Dig. Dis. Sci. | pmid:8769290 |
| Horiguchi T et al. | Pulmonary responses to heparin-protamine complexes: the effects of age and species. | 1996 | J. Appl. Physiol. | pmid:8847332 |
| Gabriel A et al. | Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta. | 1996 | J. Cardiothorac. Vasc. Anesth. | pmid:8850397 |
| Chen SJ et al. | Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. | 1996 | Gen. Pharmacol. | pmid:8853295 |
| Suehiro T et al. | Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor. | 1996 | J. Surg. Res. | pmid:8632642 |
| Garvin PJ et al. | Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. | 1996 | Transplantation | pmid:8633364 |
| Isenring P et al. | Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8992495 |
| Leung S et al. | Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9014216 |
| Hirakata H et al. | Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. | 1996 | Anesthesiology | pmid:8968193 |
| Leung LK and Glauert HP | Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. | 1996 | Toxicol. Lett. | pmid:8644126 |
| Hibi S et al. | Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase. | 1996 | J. Med. Chem. | pmid:8759636 |
| Schaefer WR et al. | Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. | 1996 | Prostaglandins | pmid:8875634 |
| van der Weiden RM et al. | Prostanoid excretion in incipient singleton and twin pregnancies. | 1996 | Am. J. Obstet. Gynecol. | pmid:9065139 |
| Cheng Z et al. | Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey. | 1996 | J. Vet. Pharmacol. Ther. | pmid:8735424 |
| Siler-Khodr TM et al. | Dose-related action of estradiol on placental prostanoid prediction. | 1996 | Prostaglandins | pmid:8873234 |
| Prié S et al. | Eosinophils and neutrophils modify arachidonic acid-induced relaxation of guinea-pig trachea. | 1996 | Eur. J. Pharmacol. | pmid:8997620 |
| Yokoyama I et al. | Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation. | 1996 | J. Surg. Res. | pmid:8592420 |
| Thwaites BK et al. | Intravenous ketorolac tromethamine worsens platelet function during knee arthroscopy under spinal anesthesia. | 1996 | Anesth. Analg. | pmid:8638787 |
| Landoni MF and Lees P | Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. | 1996 | J. Vet. Pharmacol. Ther. | pmid:8971676 |
| Sergeev PV et al. | [Human thrombocytes as a test system for the study of nongenomic effects of glucocorticoid hormones]. | 1996 | Biull Eksp Biol Med | pmid:8974481 |
| Mathieu P et al. | [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study]. | 1996 | Pathol. Biol. | pmid:8977914 |
| Han JA and Hu WY | [Progress in the study on protective effect of saponins Panax notoginseng on ischemic brain damage]. | 1996 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:9387754 |
| Liu Z | [Effects of acupuncture on lipid, TXB2, 6-keto-PGF, alpha in simple obese patients complicated with hyperlipidemia]. | 1996 | Zhen Ci Yan Jiu | pmid:9388312 |
| Li T et al. | [Observation on TXB2 and 6-keto-PGF1 alpha in serum of patients with cor pulmonale]. | 1996 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:9389073 |
| Hirashima Y et al. | Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. | 1996 | J. Neurosurg. | pmid:8622157 |
| Korn RL et al. | The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. | 1996 | J. Thorac. Cardiovasc. Surg. | pmid:8622305 |
| McAdam B et al. | Transdermal modification of platelet function: an aspirin patch system results in marked suppression of platelet cyclooxygenase. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8627531 |
| Chou TC et al. | The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation. | 1996 | Thromb. Res. | pmid:8897698 |
| Harada Y et al. | Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. | 1996 | Prostaglandins | pmid:8900441 |
| Saji T et al. | [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. | 1996 | J Cardiol | pmid:8642506 |
| Tsunomori M et al. | 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. | 1996 | Biochim. Biophys. Acta | pmid:8679681 |
| Livingston ER et al. | Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. | 1996 | Circulation | pmid:8901751 |
| Serebruany VL et al. | Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. | 1996 | Pharmacology | pmid:8902873 |
| Martin W et al. | Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. | 1996 | Eur J Cardiothorac Surg | pmid:8905281 |
| Montuschi P et al. | Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. | 1996 | Eur. J. Pharmacol. | pmid:8905345 |
| Friedman M et al. | Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. | 1996 | J. Thorac. Cardiovasc. Surg. | pmid:8583821 |
| Schmid P et al. | Passive smoking and platelet thromboxane. | 1996 | Thromb. Res. | pmid:8907294 |
| Fox GA et al. | Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. | 1996 | J. Cardiovasc. Pharmacol. | pmid:8797133 |
| Chello M et al. | Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease. | 1996 | J. Cardiovasc. Pharmacol. | pmid:8907804 |
| Szekacs B et al. | Prostacyclin and thromboxane production of rat and cat arterial tissue is altered independently by several vasoactive substances. | 1996 | Prostaglandins | pmid:8908622 |
| Serebruany VL et al. | Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swine. | 1996 | J. Cardiovasc. Pharmacol. | pmid:8961080 |
| Gries A et al. | Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. | 1996 | Arterioscler. Thromb. Vasc. Biol. | pmid:8963722 |
| Fukushima C et al. | Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma. | 1996 | Ann. Allergy Asthma Immunol. | pmid:8970439 |
| González ET et al. | Prostanoid modulation of glucose transport in isolated diabetic rat uterus. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8804128 |
| Takase B et al. | Arachidonic acid metabolites in acute myocardial infarction. | 1996 | Angiology | pmid:8686958 |
| Uematsu T et al. | Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. | 1996 | J. Pharm. Pharmacol. | pmid:8794987 |
| Sakurai S et al. | Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities. | 1996 | Chem. Pharm. Bull. | pmid:8795270 |
| Milani M et al. | Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. | 1996 | Biomed. Pharmacother. | pmid:8952866 |
| Morrow JD et al. | Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. | 1996 | J. Biol. Chem. | pmid:8798513 |
| Fekkes D et al. | Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8804122 |
| Feng J et al. | Beneficial effects of iloprost cardioplegia in ischemic arrest in isolated working rat heart. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8804125 |
| Gennaro M et al. | Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. | 1996 | Cardiovasc Surg | pmid:8782946 |
| Fimognari FL et al. | Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. | 1996 | J. Lab. Clin. Med. | pmid:8759943 |
| Xing X and Xia S | [The injury of liver sinusoidal endothelial cells in a rat's isolated liver perfusion (ILP) model for regional chemotherapy]. | 1996 | Zhonghua Wai Ke Za Zhi | pmid:9275689 |
| Kuroiwa M et al. | Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. | 1996 | Int. J. Hematol. | pmid:8762814 |
| Fuse I et al. | Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency. | 1996 | Int. J. Hematol. | pmid:8762815 |
| Yoshida SH et al. | Dietary Juniperis virginiensis seed oil decreased pentobarbital-associated mortalities among DBA/1 mice treated with collagen-adjuvant emulsions. | 1996 | J Lipid Mediat Cell Signal | pmid:8816989 |
| Galbraith EA and McKellar QA | Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. | 1996 | Res. Vet. Sci. | pmid:8819199 |
| Davì G et al. | Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. | 1996 | Thromb. Haemost. | pmid:8819248 |
| Wagner RS et al. | Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. | 1996 | Shock | pmid:8821102 |
| Landoni MF et al. | Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. | 1996 | Res. Vet. Sci. | pmid:8819190 |
| Watanabe M et al. | [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome]. | 1996 | Nihon Jinzo Gakkai Shi | pmid:8828355 |
| Meenan J et al. | Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. | 1996 | Eur J Gastroenterol Hepatol | pmid:8823572 |
| Uhlig S et al. | Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. | 1996 | Mol. Med. | pmid:8784790 |